How much can investors make with Eledon Pharmaceuticals Inc (ELDN) stock in the next 12 months?

Ulysses Smith

Eledon Pharmaceuticals Inc [ELDN] stock prices are saw in change for the day to $1.59 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ELDN shares have gain 2.58% over the last week, with a monthly amount drifted -61.78%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Previously, Guggenheim started tracking the stock with Buy rating on January 28, 2025, and set its price target to $9. Cantor Fitzgerald started tracking the stock assigning an Overweight rating and suggested a price target of $25 on March 23, 2021.

The stock price of Eledon Pharmaceuticals Inc [ELDN] has been fluctuating between $1.35 and $5.08 over the past year. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. Eledon Pharmaceuticals Inc [NASDAQ: ELDN] shares were valued at $1.59 at the most recent close of the market. An investor can expect a potential return of 466.04% based on the average ELDN price forecast.

Analyzing the ELDN fundamentals

Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at -225.16%, Pretax Profit Margin comes in at -206.66%, and Net Profit Margin reading is -207.78%. To continue investigating profitability, this company’s Return on Assets is posted at -0.61, Equity is -0.85 and Total Capital is -0.75. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.5500 points at the first support level, and at 1.5100 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.6500, and for the 2nd resistance point, it is at 1.7100.

Ratios To Look Out For

It’s worth pointing out that Eledon Pharmaceuticals Inc [NASDAQ:ELDN]’s Current Ratio is 6.74. In addition, the Quick Ratio stands at 6.74 and the Cash Ratio stands at 0.26.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.